Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Novo Nordisk bets on Emcure to win India’s weight-loss drug war

Summary by Live Mint
Danish drugmaker Novo Nordisk has teamed up with Emcure Pharmaceuticals to increase access to its weight-loss drug semaglutide in India, introducing it as a second brand, Poviztra. The collaboration aims to enhance accessibility in the competitive anti-obesity market.

1 Articles

Live MintLive Mint
Center

Novo Nordisk bets on Emcure to win India’s weight-loss drug war

Danish drugmaker Novo Nordisk has teamed up with Emcure Pharmaceuticals to increase access to its weight-loss drug semaglutide in India, introducing it as a second brand, Poviztra. The collaboration aims to enhance accessibility in the competitive anti-obesity market.

·New Delhi, India
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Live Mint broke the news in New Delhi, India on Monday, November 10, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

GLP-1 icon

GLP-1

India icon

India

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal